U.S. Cellular Health Screening Market Size & Outlook
U.S. cellular health screening market, 2018-2030 (US$M)
Related Markets
U.S. cellular health screening market highlights
- The U.S. cellular health screening market generated a revenue of USD 1,398.4 million in 2023 and is expected to reach USD 2,617.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 9.4% from 2024 to 2030.
- In terms of segment, single test panels was the largest revenue generating test type in 2023.
- Multi-test Panels is the most lucrative test type segment registering the fastest growth during the forecast period.
Cellular health screening market data book summary
| Market revenue in 2023 | USD 1,398.4 million |
| Market revenue in 2030 | USD 2,617.3 million |
| Growth rate | 9.4% (CAGR from 2023 to 2030) |
| Largest segment | Single test panels |
| Fastest growing segment | Multi-test Panels |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Test Panels, Multi-test Panels |
| Key market players worldwide | Cytek Biosciences Inc, Quest Diagnostics Inc, Labcorp Holdings Inc, OPKO Health Inc, Applied DNA Sciences Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 46.2% of the global cellular health screening market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. cellular health screening market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 242.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cellular Health Screening Market Scope
Cellular Health Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. cellular health screening market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cellular health screening market will help companies and investors design strategic landscapes.
Single test panels was the largest segment with a revenue share of 78.86% in 2023. Horizon Databook has segmented the U.S. cellular health screening market based on single test panels, multi-test panels covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. cellular health screening market held the largest revenue share and is expected to maintain its position in the future. Its dominance can be attributed to high healthcare expenditure, well established healthcare infrastructure.
favorable reimbursement scenario, and increasing adoption of cellular screening due to rising awareness about chronic & rare diseases. According to data published by the National Institutes of Health (NIH), approximately 125 million.
individuals live with some form of chronic inflammatory disease in the U.S. The increasing rate of chronic inflammation accelerates the expenditure for an American, as a patient with this disease spends nearly USD 38,000+ each year.
Reasons to subscribe to U.S. cellular health screening market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. cellular health screening market databook
-
Our clientele includes a mix of cellular health screening market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. cellular health screening market , including forecasts for subscribers. This country databook contains high-level insights into U.S. cellular health screening market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. cellular health screening market size, by test type, 2018-2030 (US$M)
U.S. Cellular Health Screening Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
